Azienda Sanitaria Universitaria Giuliano Isontina

The medical center is at the forefront of cardiology research, particularly in the treatment of inflammatory cardiomyopathy. The center's studies focus on innovative therapies that aim to improve patient outcomes by addressing the underlying inflammatory processes.

• Inflammatory Cardiomyopathy
• Chronic Myocarditis
• Heart Failure Phenotypes

Through its research, the center is contributing to a deeper understanding of the genotype-environment interactions that influence these conditions, paving the way for personalized treatment approaches.

In the field of oncology, the center is pioneering studies on locally advanced basal cell carcinoma and other malignancies. By exploring novel treatment regimens, the center aims to enhance patient compliance and treatment efficacy.

• Basal Cell Carcinoma
• Diffuse Large B-Cell Lymphoma
• Follicular Lymphoma

The center's research is instrumental in developing tailored therapeutic strategies that improve survival rates and quality of life for cancer patients.

The center is advancing the treatment of pulmonary arterial hypertension and related conditions through cutting-edge research. By evaluating new therapeutic agents, the center seeks to improve exercise capacity and overall health outcomes for patients.

• Pulmonary Arterial Hypertension
• Progressive Pulmonary Fibrosis
• Combined Postcapillary and Precapillary Pulmonary Hypertension

These studies are crucial in developing effective treatments that address both the symptoms and progression of pulmonary diseases.

In hematology, the center is exploring innovative treatments for conditions such as chronic lymphocytic leukemia and primary immune thrombocytopenia. The research focuses on improving progression-free survival and treatment response rates.

• Chronic Lymphocytic Leukemia
• Primary Immune Thrombocytopenia
• Multiple Myeloma

By investigating new drug combinations and treatment protocols, the center is enhancing therapeutic options for patients with hematological disorders.

The center is conducting pivotal research in ophthalmology, particularly focusing on neovascular age-related macular degeneration. The studies aim to assess the long-term safety and efficacy of innovative delivery systems for ocular treatments.

• Neovascular Age-Related Macular Degeneration

This research is vital in developing sustainable treatment options that maintain vision and improve the quality of life for patients with degenerative eye diseases.